Wednesday, July 8, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda clinical programs — 1179 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
1179
Drugs
359
Patents
1436
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Clinical Programs

Takeda projects

1,179 ClinicalTrials.gov programs sponsored by Takeda.

Takeda has 1,179 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

1,179 programs

Clinical programs

Page 23 of 25

  1. HYQVIA

    Takeda

    Primary Immunodeficiency Diseases (PID)

    approved mab completed

    2 trials

  2. Idursulfase

    Takeda

    Hunter Syndrome

    approved mab completed

    2 trials

  3. Ixazomib

    Takeda

    Relapsed and/or Refractory Multiple Myeloma

    approved small molecule terminated

    4 trials

  4. Lansoprazole

    Takeda

    Gastroesophageal Reflux

    approved small molecule completed

    1 trial

  5. Lansoprazole

    Takeda

    Functional Dyspepsia

    approved small molecule terminated

    1 trial

  6. Lansoprazole (Prevacid)

    Takeda

    Zollinger-Ellison Syndrome

    approved small molecule completed

    1 trial

  7. Lanthanum carbonate

    Takeda

    Kidney Failure, Chronic

    approved small molecule completed

    6 trials

  8. Lanthanum carbonate

    Takeda

    Kidney Diseases

    approved small molecule terminated

    2 trials

  9. Leuprorelin

    Takeda

    Central Precocious Puberty

    approved small molecule completed

    1 trial

  10. Leuprorelin Acetate Depot 3M

    Takeda

    Central Precocious Puberty

    approved small molecule completed

    1 trial

  11. Lisdexamfetamine dimesylate

    Takeda

    Attention Deficit Hyperactivity Disorder (ADHD)

    approved small molecule completed

    1 trial

  12. Lisdexamfetamine dimesylate

    Takeda

    Attention-deficit/Hyperactivity Disorder

    approved small molecule completed

    3 trials

  13. Lubiprostone

    Takeda

    Constipation

    approved small molecule completed

    7 trials

  14. Lubiprostone

    Takeda

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  15. Lubiprostone

    Takeda

    Inflammatory Bowel Disease

    approved small molecule completed

    1 trial

  16. MMX Mesalamine

    Takeda

    Ulcerative Colitis

    approved small molecule completed

    2 trials

  17. MMX mesalamine/ mesalazine

    Takeda

    Ulcerative Colitis

    approved small molecule completed

    1 trial

  18. Manidipine 20mg

    Takeda

    Hypertension

    approved small molecule terminated

    1 trial

  19. Maribavir

    Takeda

    Transplant Complication

    approved small molecule completed

    1 trial

  20. Metformin

    Takeda

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

  21. Midodrine HCl

    Takeda

    Orthostatic Hypotension

    approved small molecule completed

    1 trial

  22. Midodrine HCl

    Takeda

    Symptomatic Orthostatic Hypotension

    approved small molecule completed

    1 trial

  23. Midodrine Hydrochloride

    Takeda

    Hypotension, Orthostatic

    approved small molecule completed

    2 trials

  24. Mixed amphetamine salts (ADDERALL XR)

    Takeda

    ADHD

    approved small molecule completed

    1 trial

  25. NESINA ACT TAB. 25/15mg

    Takeda

    Diabetes

    approved small molecule active

    1 trial

  26. Naltrexone HCl/Bupropion HCl Placebo

    Takeda

    Weight Regain Post Bariatric Surgery

    approved small molecule terminated

    1 trial

  27. Niraparib

    Takeda

    Epithelial Ovarian Cancer

    approved small molecule active

    1 trial

  28. Octocog alfa (recombinant human coagulation factor VIII) [ADVATE]

    Takeda

    Hemophilia A

    approved mab completed

    2 trials

  29. Pantoprazole

    Takeda

    Gastroesophageal Reflux

    approved small molecule completed

    3 trials

  30. Pantoprazole

    Takeda

    Gastroesophageal Reflux Disease

    approved small molecule completed

    2 trials

  31. Pioglitazone

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    9 trials

  32. Pioglitazone

    Takeda

    Bone Metabolism

    approved small molecule completed

    1 trial

  33. Pioglitazone

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    2 trials

  34. Pioglitazone

    Takeda

    Type II Diabetes Mellitus

    approved small molecule completed

    1 trial

  35. Pioglitazone

    Takeda

    Diabetes Type 2

    approved small molecule completed

    1 trial

  36. Pioglitazone

    Takeda

    Obesity

    approved small molecule completed

    1 trial

  37. Pioglitazone

    Takeda

    Nonalcoholic Steatohepatitis

    approved small molecule completed

    1 trial

  38. Pioglitazone

    Takeda

    Metabolic Syndrome

    approved small molecule completed

    1 trial

  39. Pioglitazone 15mg

    Takeda

    Inflammation

    approved small molecule completed

    1 trial

  40. Pioglitazone and insulin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    2 trials

  41. Pioglitazone and metformin

    Takeda

    Diabetes Mellitus

    approved small molecule completed

    5 trials

  42. Pioglitazone then Placebo

    Takeda

    Diabetes

    approved small molecule completed

    1 trial

  43. Placebo

    Takeda

    Post-Traumatic Stress Disorder

    approved small molecule completed

    1 trial

  44. Placebo

    Takeda

    Chronic Insomnia

    approved small molecule terminated

    1 trial

  45. Prednisone

    Takeda

    Crohn's Disease

    approved small molecule terminated

    1 trial

  46. REPLAGAL

    Takeda

    Fabry Disease

    approved small molecule active

    5 trials

  47. RIXUBIS: On-Demand

    Takeda

    Hemophilia B

    approved mab completed

    1 trial

  48. RYMPHYSIA

    Takeda

    Chronic Obstructive Pulmonary Disease (COPD)

    approved mab terminated

    1 trial

Frequently asked questions

How many clinical projects does Takeda have?

1,179 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.